Your browser doesn't support javascript.
loading
Development of CDX-1140, an agonist CD40 antibody for cancer immunotherapy.
Vitale, Laura A; Thomas, Lawrence J; He, Li-Zhen; O'Neill, Thomas; Widger, Jenifer; Crocker, Andrea; Sundarapandiyan, Karuna; Storey, James R; Forsberg, Eric M; Weidlick, Jeffrey; Baronas, April R; Gergel, Lauren E; Boyer, James M; Sisson, Crystal; Goldstein, Joel; Marsh, Henry C; Keler, Tibor.
Affiliation
  • Vitale LA; Celldex Therapeutics, Inc, 53 Frontage Road, Suite 220, Hampton, NJ, 08827, USA.
  • Thomas LJ; Celldex Therapeutics, Inc, Needham, MA, USA.
  • He LZ; Celldex Therapeutics, Inc, 53 Frontage Road, Suite 220, Hampton, NJ, 08827, USA.
  • O'Neill T; Celldex Therapeutics, Inc, 53 Frontage Road, Suite 220, Hampton, NJ, 08827, USA.
  • Widger J; Celldex Therapeutics, Inc, 53 Frontage Road, Suite 220, Hampton, NJ, 08827, USA.
  • Crocker A; Celldex Therapeutics, Inc, 53 Frontage Road, Suite 220, Hampton, NJ, 08827, USA.
  • Sundarapandiyan K; Celldex Therapeutics, Inc, 53 Frontage Road, Suite 220, Hampton, NJ, 08827, USA.
  • Storey JR; Celldex Therapeutics, Inc, Needham, MA, USA.
  • Forsberg EM; Celldex Therapeutics, Inc, Needham, MA, USA.
  • Weidlick J; Celldex Therapeutics, Inc, 53 Frontage Road, Suite 220, Hampton, NJ, 08827, USA.
  • Baronas AR; Celldex Therapeutics, Inc, Needham, MA, USA.
  • Gergel LE; Celldex Therapeutics, Inc, Needham, MA, USA.
  • Boyer JM; Celldex Therapeutics, Inc, Needham, MA, USA.
  • Sisson C; Celldex Therapeutics, Inc, 53 Frontage Road, Suite 220, Hampton, NJ, 08827, USA.
  • Goldstein J; Celldex Therapeutics, Inc, 53 Frontage Road, Suite 220, Hampton, NJ, 08827, USA.
  • Marsh HC; Celldex Therapeutics, Inc, Needham, MA, USA.
  • Keler T; Celldex Therapeutics, Inc, 53 Frontage Road, Suite 220, Hampton, NJ, 08827, USA. tkeler@celldex.com.
Cancer Immunol Immunother ; 68(2): 233-245, 2019 Feb.
Article in En | MEDLINE | ID: mdl-30382327

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CD40 Antigens / Immunotherapy / Antibodies, Monoclonal / Neoplasms Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2019 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CD40 Antigens / Immunotherapy / Antibodies, Monoclonal / Neoplasms Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2019 Document type: Article Affiliation country: Estados Unidos